|
PELI1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.318300E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.494300E-02 |
| Normal-vs-Stage2 |
5.242400E-01 |
| Normal-vs-Stage3 |
9.617400E-01 |
| Normal-vs-Stage4 |
7.570200E-01 |
| Stage1-vs-Stage2 |
3.235000E-01 |
| Stage1-vs-Stage3 |
9.811600E-02 |
| Stage1-vs-Stage4 |
4.802400E-01 |
| Stage2-vs-Stage3 |
6.381600E-01 |
| Stage2-vs-Stage4 |
9.998800E-01 |
| Stage3-vs-Stage4 |
7.493600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.467800E-02 |
| Normal-vs-AfricanAmerican |
4.740400E-01 |
| Normal-vs-Asian |
5.092400E-01 |
| Caucasian-vs-AfricanAmerican |
2.966200E-01 |
| Caucasian-vs-Asian |
8.260600E-01 |
| AfricanAmerican-vs-Asian |
8.865400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.198000E-02 |
| Normal-vs-Female |
9.643800E-01 |
| Male-vs-Female |
2.185600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.153800E-02 |
| Normal-vs-Extreme_Weight |
1.082100E-02 |
| Normal-vs-Obese |
9.500200E-01 |
| Normal-vs-Extreme_Obese |
1.943920E-02 |
| Normal_Weight-vs-Extreme_Weight |
7.467400E-01 |
| Normal_Weight-vs-Obese |
6.678200E-02 |
| Normal_Weight-vs-Extreme_Obese |
5.147000E-01 |
| Extreme_Weight-vs-Obese |
1.159650E-02 |
| Extreme_Weight-vs-Extreme_Obese |
5.714800E-01 |
| Obese-vs-Extreme_Obese |
1.130810E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.062000E-01 |
| Normal-vs-Age(41-60Yrs) |
2.972400E-01 |
| Normal-vs-Age(61-80Yrs) |
2.672000E-02 |
| Normal-vs-Age(81-100Yrs) |
8.282400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.576400E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.555600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.486100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.885790E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.474400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.342800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.861900E-02 |
| Normal-VS-Type2 PRCC |
1.517500E-02 |
| Normal-VS-KIRP CIMP |
6.831600E-02 |
| Normal-VS-Unclassified PRCC |
5.848600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.905600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.878390E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
2.321700E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.360660E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
1.676440E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.809780E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.164900E-04 |
| Normal-vs-N1 |
2.277000E-01 |
| Normal-vs-N2 |
8.360600E-01 |
| N0-vs-N1 |
1.075630E-02 |
| N0-vs-N2 |
1.608210E-01 |
| N1-vs-N2 |
5.507600E-01 |
|
|
